newsfilter
← Latest News
GlobeNewswire·

Instil Bio to Present Novel TIL Analytics at American Society of Gene and Cell Therapy (ASGCT)

DALLAS, May 18, 2022 (GLOBE NEWSWIRE) -- Instil Bio, Inc. ("Instil") (NASDAQ:TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announ